APL-1202
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for APL-1202, covering 2020-07-20 to 2022-02-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients [Phase 3]